Seratrodast

CAS No. 112665-43-7

Seratrodast( AA2414 | A-73001 | ABT-001 )

Catalog No. M10444 CAS No. 112665-43-7

Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 39 In Stock
25MG 59 In Stock
50MG 77 In Stock
100MG 128 In Stock
200MG 165 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Seratrodast
  • Note
    Research use only, not for human use.
  • Brief Description
    Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.
  • Description
    Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma. It was the first TP receptor antagonist that was developed as an anti-asthmatic drug and received marketing approval in Japan in 1997.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AA2414 | A-73001 | ABT-001
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX| TXA2R
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    112665-43-7
  • Formula Weight
    354.44
  • Molecular Formula
    C22H26O4
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    O=C(O)CCCCCC(C(C1=O)=C(C)C(C(C)=C1C)=O)C2=CC=CC=C2
  • Chemical Name
    (+-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Endo S, Akiyama K. Nihon Rinsho. 1996 Nov;54(11):3045-8.
molnova catalog
related products
  • Firocoxib

    Firocoxib is a selective non-steroidal inhibitor of cycooxygenase-2 (COX-2) (IC50 of 0.13 μM), with anti-inflammatory for use in dogs and horses.

  • Meloxicam

    Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve the symptoms of arthritis (juvenile rheumatoid arthritis, osteoarthritis, and rheumatoid arthritis), such as inflammation, swelling, stiffness, and joint pain.

  • Mollugin

    Mollugin may be a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway.